Suman

Siam

Shradha

Ritesh

Rahul

Prem

Narayan

Himesh

Biswajit

Arti
images 8

The USFDA has given Zydus Cadila preliminary approval to market the cancer medication ‘Lenalidomide’

New Delhi, India: Zydus Cadila, a pharmaceutical company, announced on Tuesday that it has gotten conditional approval from the US Food and Drug Administration to market Lenalidomide Capsules, which are used to treat certain types of malignancies. The US Fo...

18 August, 2021

Read more
vaccination

Pfizer-BioNTech submit preliminary data for Covid-19 vax booster approval

Pfizer Inc and its German partner BioNTech SE have submitted to US regulators the initial data from an early-stage trial toward seeking authorization of a booster dose of their Covid-19 vaccine, the drugmakers said on Monday. They said the third dose showed...

16 August, 2021

Read more
johnson and johnson covid vaccine

COVID-19 vaccine: J&J doses may not arrive until November, Zydus Cadila is expected next, and Covaxin expansion is a priority

The government expects the first doses of Johnson & Johnson’s (J&J) single-shot vaccine to arrive in November or December, according to a top government source, after the government granted the foreign vaccine manufacturer Emergency Use Author...

15 August, 2021

Read more
Bharat

The DCGI has approved a phase II/III trial of Bharat Biotech’s nasal Covid vaccination

The Union ministry of science announced on Friday that Bharat Biotech has received authorisation from India’s pharma regulator to undertake mid-to late-stage trials of their nasal Covid-19 vaccine candidate. “This is the first Covid-19 vaccine to go t...

14 August, 2021

Read more

Adults need a second Covid-19 booster injection: Moderna

19 March, 2022

Prescribes Raids on Erring Pharma Firms, Health Ministry has asked ...

17 March, 2022

New York state data on Pfizer/BioNTech vaccine has EMA unconcerned

4 March, 2022

Moderna’s Covid Jab Gets EU Approval For Kids Aged 6-11

25 February, 2022

mRNA Covid vaccine scientist Dr Weissman and team working on develo...

24 February, 2022

Biological E’s Corbevax gets DCGI nod

22 February, 2022

Sources say CDL Kasauli cleared around 6.5 crore doses of Corbevax

22 February, 2022

Lupin’s antibiotic drug gets USFDA nod

18 February, 2022

Moderna expecting Covid-19 booster by August, unsure on Omicron spe...

17 February, 2022

Pfizer and BioNTech Omicron vaccine delayed: BioNTech CEO

17 February, 2022

Israel approves AstraZeneca Covid drug for people with weak immunity

16 February, 2022

Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age g...

14 February, 2022

China approves Pfizer’s Covid drug Paxlovid

12 February, 2022

Emcure Pharma arm developing Omicron specific Covid vaccine

11 February, 2022

DCGI nod to SII to make COVID vaccine against Omicron for test, ana...

8 February, 2022

Sputnik Light the second vaccine to be made available in India by D...

7 February, 2022

Pfizer asks FDA to allow Covid-19 vaccine for children under 5

2 February, 2022

Nasal Covid-19 vaccine to be a gamechanger: AIIMS epidemiologist

31 January, 2022

Moderna begins trial of Omicron specific vaccine

27 January, 2022

Covishield, Covaxin to be capped at ₹ 275 each post getting marketi...

27 January, 2022